Perspective Therapeutics Inc. (CATX) stock forecast · $280.6M cap
Perspective Therapeutics Inc. (CATX) is a medical devices company listed on US.
This CATX forecast page states what the cached financials imply — not a price target and not a guarantee. Perspective Therapeutics Inc. outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for CATX yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for CATX, so this page does not invent a growth rate.
CATX currently screens at market cap $280.6M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next CATX 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the CATX stock page.
Not investment advice.